http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101771695-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-02 |
| filingDate | 2014-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101771695-B1 |
| titleOfInvention | Pharmaceutical composition for the prevention and treatment of obesity comprising Spirulina maxima as an active ingredient |
| abstract | The present invention relates to a pharmaceutical composition for preventing or treating Spirulina extract and its components such as Allophycocyanin (APC), R-phycoerythrin (R-PE) and C-phycocyanin (C-PC) The present invention relates to a spirulina extract and its components, alopicosane, al-picoerythrine, and cipicocyanin, which are free of toxicity to cells and have excellent lipidation effect, It can be usefully used as a pharmaceutical composition for prevention and treatment of obesity and as a health functional food for improvement. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210096036-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102281855-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200104449-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190139793-A |
| priorityDate | 2014-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 131.